Atlas

Form 483

Manhattan Cryobank Inc. Form 483, 2013-07-02

FDA issued a Form 483 to Manhattan Cryobank Inc. on 2013-07-02 with 2 public-safe observations.

483· Form 483 issuedBiologics2 observations

Manhattan Cryobank Inc. · New York, United States · Issued July 2, 2013

Overview

  • 2 public-safe observations are available for this inspection.
  • 2 structured CFR citations are represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

2 Jul 2013
21 CFR 1271.47(a)

Testing, screening, donor eligibility procedures

Cited by Evelyn Taha

2 Jul 2013
21 CFR 1271.75(a)(2)

Risks associated with xenotransplantation

Cited by Evelyn Taha

Inspected site

MCManhattan Cryobank Inc.New York, United States

Inspection team

ETEvelyn Taha

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 1271.47(a)Cited across public-safe Form 483 observations1x
21 CFR 1271.75(a)(2)Cited across public-safe Form 483 observations1x

Full 483 report

Get the verbatim text of all 2 observations

Every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere